三上悠亚久久精品,少妇spa推油被扣高潮,波多野结av衣东京热无码专区,亚洲乱码中文字幕久久孕妇黑人
<noscript id="i094l"><dfn id="i094l"></dfn></noscript>
Stock Code
603707.SH
ABOUT
>
Company profile
Enterprise Culture
Early Warning System
BUSINESS
>
Commercialized Products
MEDIA
>
News in NKF
CONTACT
CH / EN
Home
>
MEDIA
>
News in NKF
>
King-Friend will meet you in CPHI Shanghai!
2025-05-13
King-Friend will meet you in CPHI Shanghai!
share
Return
Previous
NKF's Liraglutide Injection gets FDA approval for marketing
Next
NKF's Rocuronium Bromide Injection getting approved by NMPA
Relevant recommendations
2025-05-26
NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing
2025-05-22
NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing
2025-05-20
Paclitaxel For Injection (Albumin Bound) approved by US FDA
2025-05-19
King-Friend will meet you in CPHI Frankfurt!
2025-04-04
NKF's Liraglutide Injection gets FDA approval for marketing
ABOUT
BUSINESS
MEDIA
CONTACT
Stock price
11.160
-0.029999999999999
?2025 Nanjing King-Friend Biochemical Pharmaceutical Co.Ltd
蘇ICP備13012010號
Disclaimers
Privacy policy
Site map
